JD Health International Statistics

Total Valuation

FRA:8ZN has a market cap or net worth of EUR 21.28 billion. The enterprise value is 15.37 billion.

Market Cap	21.28B
Enterprise Value	15.37B

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	3.20B
Shares Outstanding	n/a
Shares Change (YoY)	+0.53%
Shares Change (QoQ)	+0.79%
Owned by Insiders (%)	0.83%
Owned by Institutions (%)	12.09%
Float	1.03B

Valuation Ratios

The trailing PE ratio is 37.92 and the forward PE ratio is 27.43.

PE Ratio	37.92
Forward PE	27.43
PS Ratio	2.75
PB Ratio	3.09
P/TBV Ratio	3.20
P/FCF Ratio	21.61
P/OCF Ratio	21.45
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.86, with an EV/FCF ratio of 15.61.

EV / Earnings	27.39
EV / Sales	1.95
EV / EBITDA	52.86
EV / EBIT	58.50
EV / FCF	15.61

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.01.

Current Ratio	2.92
Quick Ratio	2.53
Debt / Equity	0.01
Debt / EBITDA	0.17
Debt / FCF	0.05
Interest Coverage	270.34

Financial Efficiency

Return on equity (ROE) is 8.56% and return on invested capital (ROIC) is 2.54%.

Return on Equity (ROE)	8.56%
Return on Assets (ROA)	1.93%
Return on Invested Capital (ROIC)	2.54%
Return on Capital Employed (ROCE)	3.85%
Revenue Per Employee	1.69M
Profits Per Employee	122,738
Employee Count	3,564
Asset Turnover	0.89
Inventory Turnover	7.55

Taxes

In the past 12 months, FRA:8ZN has paid 60.26 million in taxes.

Income Tax	60.26M
Effective Tax Rate	9.71%

Stock Price Statistics

The stock price has increased by +92.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+92.53%
50-Day Moving Average	6.93
200-Day Moving Average	5.50
Relative Strength Index (RSI)	42.38
Average Volume (20 Days)	644

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:8ZN had revenue of EUR 7.74 billion and earned 561.16 million in profits. Earnings per share was 0.18.

Revenue	7.74B
Gross Profit	1.84B
Operating Income	268.03M
Pretax Income	620.58M
Net Income	561.16M
EBITDA	288.12M
EBIT	268.03M
Earnings Per Share (EPS)	0.18

Full Income Statement

Balance Sheet

The company has 5.86 billion in cash and 51.07 million in debt, giving a net cash position of 5.81 billion.

Cash & Cash Equivalents	5.86B
Total Debt	51.07M
Net Cash	5.81B
Net Cash Per Share	n/a
Equity (Book Value)	6.89B
Book Value Per Share	2.18
Working Capital	4.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 992.13 million and capital expenditures -7.32 million, giving a free cash flow of 984.81 million.

Operating Cash Flow	992.13M
Capital Expenditures	-7.32M
Free Cash Flow	984.81M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 23.81%, with operating and profit margins of 3.46% and 7.25%.

Gross Margin	23.81%
Operating Margin	3.46%
Pretax Margin	8.02%
Profit Margin	7.25%
EBITDA Margin	3.72%
EBIT Margin	3.46%
FCF Margin	12.73%

Dividends & Yields

FRA:8ZN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.53%
Shareholder Yield	-0.53%
Earnings Yield	2.64%
FCF Yield	4.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:8ZN has an Altman Z-Score of 3.96 and a Piotroski F-Score of 6.

Altman Z-Score	3.96
Piotroski F-Score	6